Assessing Abuse Potential of New Analgesic Medications Following Market Release: An Evaluation of Internet Discussion of Tapentadol Abuse

Publisher： John Wiley & Sons Inc

E-ISSN： 1526-4637|16|1|131-140

ISSN： 1526-2375

Source： PAIN MEDICINE, Vol.16, Iss.1, 2015-01, pp. : 131-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tapentadol Abuse Potential: A Postmarketing Evaluation Using a Sample of Individuals Evaluated for Substance Abuse Treatment

By  

PAIN MEDICINE, Vol. 16, Iss. 1, 2015-01 ,pp. : 119-130

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of the Market Withdrawal of Carisoprodol on Use of Other Prescribed Drugs With Abuse Potential

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 3, 2012-03 ,pp. : 438-441

John Wiley & Sons Inc

Access to resources Recommend Favorite

New Drugs of Abuse

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 2, 2015-02 ,pp. : 189-197

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fibrinous Anterior Uveitis Following Topical Tetracaine Abuse

By  

Current Drug Safety, Vol. 12, Iss. 3, 2017-10 ,pp. : 216-218

Bentham Science Publishers

Access to resources Recommend Favorite

Intranasal administration of crushed ALO‐02 (extended‐release oxycodone with sequestered naltrexone): A randomized, controlled abuse‐potential study in nondependent recreational opioid users

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 12, 2015-12 ,pp. : 1351-1361

John Wiley & Sons Inc

Access to resources Recommend Favorite